<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01547208</url>
  </required_header>
  <id_info>
    <org_study_id>PARTITA</org_study_id>
    <nct_id>NCT01547208</nct_id>
  </id_info>
  <brief_title>Does Timing of VT Ablation Affect Prognosis in Patients With an Implantable Cardioverter-defibrillator?</brief_title>
  <acronym>PARTITA</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>IRCCS San Raffaele</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IRCCS San Raffaele</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess whether the burden of untreated non-sustained
      ventricular tachycardias (VTs), or episodes treated with anti-tachycardia pacing, correlates
      with appropriate implantable cardiac defibrillator (ICD) shock therapies and to evaluate if
      the timing of radiofrequency VT ablation affects the prognosis of ICD recipients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Enrolled patients will remain in a first phase of the study until the first appropriate ICD
      shock will be delivered.

      The objective of this first stage is to assess whether the burden of untreated non sustained
      VTs or episodes treated with anti-tachycardia pacing is predictive of appropriate ICD shocks.

      The second phase of the study will start after the first appropriate ICD shock delivered for
      VT.

      Patients will be then randomized to immediate VT ablation or to standard treatment, meaning
      waiting until next arrhythmic storm to perform a VT ablation procedure.

      The objective of this phase is compare the rate of worsening heart failure hospitalizations
      and deaths from any cause between the two groups.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2012</start_date>
  <completion_date type="Anticipated">September 2020</completion_date>
  <primary_completion_date type="Anticipated">September 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Occurrence of the first appropriate ICD shock during phase A</measure>
    <time_frame>Event Driven</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of patients showing worsening heart failure hospitalizations or deaths from any cause during phase B</measure>
    <time_frame>Two Years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of patients showing cardiac deaths during phase B</measure>
    <time_frame>Two Years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients showing electrical storm (ES) recurrences during phase B</measure>
    <time_frame>Two Years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients showing VT recurrences during phase B</measure>
    <time_frame>Two Years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">590</enrollment>
  <condition>Ventricular Tachycardias</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will be randomized to a VT ablation procedure immediately after an appropriate ICD shock</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will wait until an arrhythmic storm to undergo a VT ablation procedure</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Immediate radiofrequency ablation of ventricular tachycardia</intervention_name>
    <description>Radiofrequency ablation of ventricular tachycardia is performed immediately after an appropriate ICD shock</description>
    <arm_group_label>Group A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Radiofrequency ablation of ventricular tachycardia</intervention_name>
    <description>Radiofrequency ablation of ventricular tachycardia will be performed after an arrhythmic storm occurs</description>
    <arm_group_label>Group B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients already implanted with ICD (single-/dual -chamber, with or without cardiac
             resynchronization therapy) for primary or secondary prevention of sudden cardiac death

        Exclusion Criteria:

        Phase A exclusion Criteria:

          -  General contraindication to transcatheter ablation

          -  Contraindication to antithrombotic therapy

          -  Patients chronically treated with class I and III antiarrhythmic drugs

        Phase B exclusion criteria:

          -  Patients developing first occurrence of incessant VTs

          -  Patients receiving a shock for first occurrence of clinically verified ventricular
             fibrillation

          -  Patients with aetiology differing from ischemic heart disease for coronary artery
             disease and from non-ischemic dilatative cardiomyopathy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paolo Della Bella</last_name>
    <role>Study Director</role>
    <affiliation>IRCCS San Raffaele</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Andrea Radinovic</last_name>
    <role>Study Director</role>
    <affiliation>IRCCS San Raffaele</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Andrea Radinovic</last_name>
    <email>radinovic.andrea@hsr.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Paolo Della Bella</last_name>
    <email>dellabella.paolo@hsr.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Brussels Heart Center</name>
      <address>
        <city>Bruxelles</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gaetano Paparella</last_name>
    </contact>
    <investigator>
      <last_name>Gaetano Paparella</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IKEM Hospital</name>
      <address>
        <city>Prague</city>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Josef Kautzner</last_name>
    </contact>
    <investigator>
      <last_name>Josef Kautzner</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital cardiologique du Haut-Lévêque</name>
      <address>
        <city>Bordeaux</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre Jais</last_name>
    </contact>
    <investigator>
      <last_name>Pierre Jais</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Herz und Gefass Klinik</name>
      <address>
        <city>Bad Neustadt</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Deneke</last_name>
    </contact>
    <investigator>
      <last_name>Thomas Deneke</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale di Desio</name>
      <address>
        <city>Desio</city>
        <state>Milan</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giuseppe Mantovani</last_name>
    </contact>
    <investigator>
      <last_name>Giuseppe Mantovani</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale di Montebelluna</name>
      <address>
        <city>Montebelluna</city>
        <state>Treviso</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diego Vaccari</last_name>
    </contact>
    <investigator>
      <last_name>Diego Vaccari</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Mater Domini</name>
      <address>
        <city>Castellanza</city>
        <state>Varese</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Massimo Tritto</last_name>
    </contact>
    <investigator>
      <last_name>Massimo Tritto</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Sant'Antonio Abate</name>
      <address>
        <city>Gallarate</city>
        <state>Varese</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniela Orsida</last_name>
    </contact>
    <investigator>
      <last_name>Daniela Orsida</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ivan Caico</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale di Mirano</name>
      <address>
        <city>Mirano</city>
        <state>Venice</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Franco Zoppo</last_name>
    </contact>
    <investigator>
      <last_name>Franco Zoppo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale S. Donato</name>
      <address>
        <city>Arezzo</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pasquale Notarstefano</last_name>
    </contact>
    <investigator>
      <last_name>Pasquale Notarstefano</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AO Policlinico di Bari</name>
      <address>
        <city>Bari</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Giuseppe Grandinetti</last_name>
    </contact>
    <investigator>
      <last_name>Giuseppe Grandinetti</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Brotzu</name>
      <address>
        <city>Cagliari</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gianfranco Tola</last_name>
    </contact>
    <investigator>
      <last_name>Gianfranco Tola</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Osp. Fondazione Giovanni Paolo II</name>
      <address>
        <city>Campobasso</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matteo Santamaria</last_name>
    </contact>
    <investigator>
      <last_name>Matteo Santamaria</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AO Pugliese Ciaccio</name>
      <address>
        <city>Catanzaro</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giampiero Maglia</last_name>
    </contact>
    <investigator>
      <last_name>Giampiero Maglia</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IRCCS San Raffaele</name>
      <address>
        <city>Milan</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrea Radinovic</last_name>
      <email>radinovic.andrea@hsr.it</email>
    </contact>
    <investigator>
      <last_name>Paolo Della bella</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andrea Radinovic</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fondazione G. Monasterio</name>
      <address>
        <city>Pisa</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marcello Piacenti</last_name>
    </contact>
    <investigator>
      <last_name>Marcello Piacenti</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Policlinico Casilino</name>
      <address>
        <city>Rome</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alessio Borrelli</last_name>
    </contact>
    <investigator>
      <last_name>Leonardo Calò</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alessio Borrelli</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Valtellina e Valchiavenna</name>
      <address>
        <city>Sondrio</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maurizio Moizi</last_name>
    </contact>
    <investigator>
      <last_name>Maurizio Moizi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Civile Maggiore</name>
      <address>
        <city>Verona</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giovanni Morani</last_name>
    </contact>
    <investigator>
      <last_name>Giovanni Morani</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centro Hospitalar Lisboa Norte, Hospital Universitário de Santa Maria</name>
      <address>
        <city>Lisbon</city>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luis Carpinteiro</last_name>
    </contact>
    <investigator>
      <last_name>Luis Carpinteiro</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lausanne Hospital</name>
      <address>
        <city>Lausanne</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Etienne P Pruvot</last_name>
    </contact>
    <investigator>
      <last_name>Etienne Pruvot</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Czechia</country>
    <country>France</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Portugal</country>
    <country>Switzerland</country>
  </location_countries>
  <removed_countries>
    <country>Czech Republic</country>
  </removed_countries>
  <reference>
    <citation>Reddy VY, Reynolds MR, Neuzil P, Richardson AW, Taborsky M, Jongnarangsin K, Kralovec S, Sediva L, Ruskin JN, Josephson ME. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med. 2007 Dec 27;357(26):2657-65.</citation>
    <PMID>18160685</PMID>
  </reference>
  <reference>
    <citation>Kuck KH, Schaumann A, Eckardt L, Willems S, Ventura R, Delacrétaz E, Pitschner HF, Kautzner J, Schumacher B, Hansen PS; VTACH study group. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet. 2010 Jan 2;375(9708):31-40. doi: 10.1016/S0140-6736(09)61755-4.</citation>
    <PMID>20109864</PMID>
  </reference>
  <reference>
    <citation>Sweeney MO, Sherfesee L, DeGroot PJ, Wathen MS, Wilkoff BL. Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients. Heart Rhythm. 2010 Mar;7(3):353-60. doi: 10.1016/j.hrthm.2009.11.027. Epub 2009 Dec 2.</citation>
    <PMID>20185109</PMID>
  </reference>
  <reference>
    <citation>Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, Reddy RK, Marchlinski FE, Yee R, Guarnieri T, Talajic M, Wilber DJ, Fishbein DP, Packer DL, Mark DB, Lee KL, Bardy GH. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med. 2008 Sep 4;359(10):1009-17. doi: 10.1056/NEJMoa071098.</citation>
    <PMID>18768944</PMID>
  </reference>
  <reference>
    <citation>Varma N, Epstein AE, Irimpen A, Schweikert R, Love C; TRUST Investigators. Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial. Circulation. 2010 Jul 27;122(4):325-32. doi: 10.1161/CIRCULATIONAHA.110.937409. Epub 2010 Jul 12.</citation>
    <PMID>20625110</PMID>
  </reference>
  <reference>
    <citation>Varma N, Michalski J, Epstein AE, Schweikert R. Automatic remote monitoring of implantable cardioverter-defibrillator lead and generator performance: the Lumos-T Safely RedUceS RouTine Office Device Follow-Up (TRUST) trial. Circ Arrhythm Electrophysiol. 2010 Oct;3(5):428-36. doi: 10.1161/CIRCEP.110.951962. Epub 2010 Aug 17.</citation>
    <PMID>20716717</PMID>
  </reference>
  <reference>
    <citation>Gilliam FR, Hayes DL, Boehmer JP, Day J, Heidenreich PA, Seth M, Jones PW, Stein KM, Saxon LA. Real world evaluation of dual-zone ICD and CRT-D programming compared to single-zone programming: the ALTITUDE REDUCES study. J Cardiovasc Electrophysiol. 2011 Sep;22(9):1023-9. doi: 10.1111/j.1540-8167.2011.02086.x. Epub 2011 May 31.</citation>
    <PMID>21627705</PMID>
  </reference>
  <reference>
    <citation>Carbucicchio C, Santamaria M, Trevisi N, Maccabelli G, Giraldi F, Fassini G, Riva S, Moltrasio M, Cireddu M, Veglia F, Della Bella P. Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators: short- and long-term outcomes in a prospective single-center study. Circulation. 2008 Jan 29;117(4):462-9. doi: 10.1161/CIRCULATIONAHA.106.686534. Epub 2008 Jan 2.</citation>
    <PMID>18172038</PMID>
  </reference>
  <reference>
    <citation>Della Bella P, Baratto F, Tsiachris D, Trevisi N, Vergara P, Bisceglia C, Petracca F, Carbucicchio C, Benussi S, Maisano F, Alfieri O, Pappalardo F, Zangrillo A, Maccabelli G. Management of ventricular tachycardia in the setting of a dedicated unit for the treatment of complex ventricular arrhythmias: long-term outcome after ablation. Circulation. 2013 Apr 2;127(13):1359-68. doi: 10.1161/CIRCULATIONAHA.112.000872. Epub 2013 Feb 25.</citation>
    <PMID>23439513</PMID>
  </reference>
  <reference>
    <citation>Vergara P, Trevisi N, Ricco A, Petracca F, Baratto F, Cireddu M, Bisceglia C, Maccabelli G, Della Bella P. Late potentials abolition as an additional technique for reduction of arrhythmia recurrence in scar related ventricular tachycardia ablation. J Cardiovasc Electrophysiol. 2012 Jun;23(6):621-7. doi: 10.1111/j.1540-8167.2011.02246.x. Epub 2012 Apr 4.</citation>
    <PMID>22486970</PMID>
  </reference>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 28, 2012</study_first_submitted>
  <study_first_submitted_qc>March 3, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 7, 2012</study_first_posted>
  <last_update_submitted>September 29, 2017</last_update_submitted>
  <last_update_submitted_qc>September 29, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 2, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>IRCCS San Raffaele</investigator_affiliation>
    <investigator_full_name>Paolo Della Bella</investigator_full_name>
    <investigator_title>Director of Arrhythmia Department and Clinical Electrophysiology Laboratories</investigator_title>
  </responsible_party>
  <keyword>ICD shocks</keyword>
  <keyword>Ventricular tachycardias ablation</keyword>
  <keyword>Timing of ablation</keyword>
  <keyword>Electrical storm</keyword>
  <keyword>Arrhythmic storm</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tachycardia</mesh_term>
    <mesh_term>Tachycardia, Ventricular</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

